Massachusetts General Hospital

M. Amin Arnaout, MD

M. Amin Arnaout, MD

Massachusetts General Hospital

A major research focus of my laboratory is the dissection of the role of leukocyte integrins in inflammation, and an elucidation of the mechanisms that regulate the functions of these adhesion receptors in health and disease.

Chad Cowan, PhD

Chad Cowan, PhD

Harvard University Department of Stem Cell and Regenerative Biology
Massachusetts General Hospital

Our research is focused on understanding the molecular underpinnings of metabolic diseases such as type 2 diabetes mellitus (T2DM) and coronary artery disease (CAD).

Patricia K. Donahoe, MD

Patricia K. Donahoe, MD

Massachusetts General Hospital
Harvard Medical School

The Pediatric Surgical Research Laboratories focus on Developmental Biology, some areas of which hold promise for clinical application to benefit both pediatric and adult patients.

Iain A. Drummond, PhD

Iain A. Drummond, PhD

Massachusetts General Hospital
Harvard Medical School

We study kidney organogenesis using the zebrafish to explore conserved molecular mechanisms underlying kidney cell specification, differentiation, and organ patterning. We also study organ pathologies that results from mutations in genes required for cilia biogenesis and function. These include kidney cystic disease, retinal degeneration and left-right asymmetry defects.

James Gusella, PhD

James Gusella, PhD

Massachusetts General Hospital
Harvard Medical School

My laboratory is focused on understanding nervous system disease using molecular genetic strategies, beginning with human patients and proceeding through in vitro and modeling studies, with the ultimate goal of improving diagnosis, management and treatment.

David M. Langenau, PhD

David M. Langenau, PhD

Massachusetts General Hospital

Our research focuses on using the zebrafish to better understand human cancer and to develop novel insights into how it is that tumors can be remade following conventional chemotherapeutic intervention. Uncovering the downstream molecular pathways that lead to relapse will be integral to identifying novel drugs for the treatment of cancer.

Harald C. Ott, MD

Harald C. Ott, MD

Massachusetts General Hospital
Harvard Medical School

Dr. Harald C. Ott is a fellow in cardiothoracic surgery at the Massachusetts General Hospital and an Instructor in Surgery at the Harvard Medical School.

Pages